FY2025 EPS Estimates for Repligen Lifted by William Blair
Repligen Co. (NASDAQ:RGEN – Free Report) – Research analysts at William Blair upped their FY2025 EPS estimates for shares of Repligen in a research note issued to investors on Wednesday, April 30th. William Blair analyst M. Larew now anticipates that the biotechnology company will earn $1.68 per share for the year, up from their previous […]
Repligen Co. (NASDAQ:RGEN – Free Report) – Research analysts at William Blair upped their FY2025 EPS estimates for shares of Repligen in a research note issued to investors on Wednesday, April 30th. William Blair analyst M. Larew now anticipates that the biotechnology company will earn $1.68 per share for the year, up from their previous […]
